Engagement, Not Satisfaction
Patient satisfaction is the oldest and most widely used metric. It's also misleading because loyalty doesn't correlate with good care.
Dialectic Medicine
Behavioral intervention has limited benefits because it doesn't address how patients think about their clinical decisions.
Mostly Uncertainty in Treating Long COVID
Dozens of major medical centers have established specialized COVID clinics around the country. A crowdsourced project counted more than 400. ...
Finding Truth in the Chaos
The truth, even on a good day, is elusive. We would do well to remember that. And perhaps judge ourselves ...
Daddy Quits Smoking
Sometimes the smoke was all he had. It rose and lifted his pains away, and sometimes he felt that it ...
Giving Thanks
Dr. Leap reminds us about the importance of gratitude, even for the mundane.
Bird Flu is Here for Thanksgiving
An outbreak of highly pathogenic avian influenza has spread through chicken and turkey flocks since it was first detected in ...
Income Uncertainty Drives Coverage Gap
More than 2 million low-income people — mostly in Florida and Texas — are uninsured because they are stuck in ...
DEA Sets CDC Opioid Guidelines
The CDC unveiled its latest opioid prescribing guidelines. It's decidedly more patient centric, but fails to account for how law ...
Declare Pandemic Uncertainty
Enough time has passed to where we are reflecting on the pandemic for a sense of closure. We would be ...
Arc of Medicare Advantage Plans
Medicare Advantage plans are facing scrutiny after years of excessive billing practices. The fraud exemplifies how delivery models cannot align ...
Resources to See Which Hospitals Are Penalized by Medicare
The federal government cuts payments to hospitals that have high rates of readmissions and those with the highest numbers of ...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more